Marker Therapeutics, Inc.

NASDAQ:MRKR

2.54 (USD) • At close January 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Operating Activities:
Net Income -14.046-29.931-41.879-28.706-21.428-147.958-10.982-2.455-34.066-30.883-5.533-5.858-2.029-5.091-4.462-2.196-3.891-1.304-0.986-2.683-5.779-2.285-0.38-1.292-1.127
Depreciation & Amortization 03.683.1631.0760.2870000000000.0040.0070.0060.0060.0720.0370.0420.04100.0210.018
Deferred Income Tax 00-7.14800000000000-0.9560-0.96400-2.73300000
Stock Based Compensation 0.8583.3055.9645.2285.35716.3512.7381.5581.7051.3910.1322.441.2622.2892.5260.2340.964002.73300000
Change In Working Capital 2.847-5.8135.4723.573-2.4821.0430.3020.2560.11-0.2132.5812.2250.0550.7290.6930.4850.361-0.258-0.161.2820.4020.2070.139-0.4520.01
Accounts Receivables 1.374-2.40210.0560.05200000000000000000000
Inventory 02.402-1-0.056-0.05200000000000000000000.028
Accounts Payables 0.611-4.3014.1414.222-0.9641.2410.2830.2580.096-0.1452.4812.033-0.066000.3890.3740.0030.0030.10600000
Other Working Capital 0.861-1.5121.331-0.649-1.518-0.1990.019-0.0010.014-0.0680.10.1930.1210.7290.6930.096-0.013-0.261-0.1631.1760.4020.2070.139-0.452-0.018
Other Non Cash Items -6.099-0.2537.148-0.031-0.018116.085-0.498-5.86927.90827.5182.125-0.373-0.5981.1481.0730.7552.2980.37-0.0910.1492.7430.630.2430.8430.284
Operating Cash Flow -16.44-26.972-27.28-18.86-18.284-14.48-8.439-6.51-4.343-2.187-0.695-1.565-1.31-0.925-1.122-0.714-1.226-1.186-1.165-1.215-2.591-1.4070.002-0.88-0.815
Investing Activities:
Investments In Property Plant And Equipment 0-4.945-3.131-10.428-0.375-0.1480000000000-0.0220-0.0020-0.002-0.0060-0.003-0.054
Acquisitions Net 0000000000000000000000000
Purchases Of Investments 0000000000000000000000000
Sales Maturities Of Investments 0000000000000000000000000
Other Investing Activites 18.664-4.945-1.559-6.789000000000000-0.022-0.002-0.002-0.00200.423000.017
Investing Cash Flow 18.664-4.945-3.131-10.428-0.375-0.1480000000000-0.022-0.002-0.002-0.002-0.0020.4180-0.003-0.037
Financing Activities:
Debt Repayment 0000000-0.04800.4030.740.7610.7250.5640.4850.1220.5830.3760.060.500.06900.185-0.083
Common Stock Issued 1.0150.20252.5536.1860.81666.9455.4082.3312.4641.87800.5550.68300.70.060.4581.0861.360.551.9641.5700.6230.972
Common Stock Repurchased 00000-0.072-0.31000000000000000000
Dividends Paid 0000000000000000000000000
Other Financing Activities 0.0900.0030.550.8164.3720.625.5018.3140-0.0310.0560.1290.2430.0770.3660.2780-0.2070.1740.044-0.013-0.00200
Financing Cash Flow 1.1050.20252.5566.7360.81671.2455.7177.78510.7782.2810.7091.3661.5370.8071.2620.5481.3181.2211.2141.2242.0081.626-0.0020.8080.888
Other Information:
Effect Of Forex Changes On Cash 0000000000000000-0.0230.03-0.002-0.017-0.037-0.00600.031-0.03
Net Change In Cash 3.329-31.71522.145-22.552-17.84356.617-2.7221.2756.4350.0930.015-0.20.227-0.1180.14-0.1670.0470.0640.045-0.008-0.6230.6310-0.0440.006
Cash At End Of Period 15.11111.78243.49721.35243.90461.7475.1297.8516.5770.1420.0490.0510.250.0240.1410.0010.1680.120.0560.0120.0190.643000.044